Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer

The aim of the present study was to determine the factors associated with reduced clinical benefits of personalized peptide vaccination (PPV) for pancreatic cancer. Phase II PPV clinical trials comprising 309 (8 non-advanced and 301 advanced-stage) patients with pancreatic cancer were conducted. Two...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchino, Yoshihiro, Muroya, Daisuke, Yoshitomi, Munehiro, Shichijo, Shigeki, Yamada, Akira, Sasada, Tetsuro, Yamada, Teppei, Okuda, Koji, Itoh, Kyogo, Yutani, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788558/
https://www.ncbi.nlm.nih.gov/pubmed/33437477
http://dx.doi.org/10.3892/mco.2020.2201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788558/
https://www.ncbi.nlm.nih.gov/pubmed/33437477
http://dx.doi.org/10.3892/mco.2020.2201

Ejemplares similares